As shown in Supplemental Figure 9, C–F, the IL-17 neutralizing antibody treatment successfully inhibited DSS-mediated colitis in WT mice but did not eliminate the colitis phenotype difference induced by Nedd4l deficiency. The gene discussed is IL17A; the disease is colitis.